What are PARP Inhibitors for Breast Cancer? | Lynparza (olaparib) Explained
Should you be taking a PARP inhibitor for breast cancer? What are the side effects? In this video, Dr. Jennifer Griggs explains what PARP inhibitors are, how they work, who is most likely to benefit from them, and common side effects. These drugs, such as Lynparza (olaparib) and Talzenna (talazoparib), are commonly used in HER2-negative breast cancers in people with a BRCA1 or BRCA2 mutation.
⭐️ Get your personalized Yerbba Report at https://www.yerbba.com/
Take control of your breast cancer treatment
Connect With Yerbba!
INSTAGRAM: / yerbba
FACEBOOK: / yerbba.breast.cancer
BLOG: https://www.yerbba.com/blog
#breastcancertreatment #brca #brca1 #brca2 #olaparib #breastcancer
Chapters
0:00 Introduction
0:36 How PARP Inhibitors Work
1:15 Who Gets Them? BRCA Mutations
3:21 Common Side Effects
Disclaimer: Yerbba YouTube videos are for informational purposes only, do not constitute medical advice, and are not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your medical team, mental health professional, or other qualified health provider with any questions you may have regarding your medical condition.
Photo used in thumbnail: https://pharmatimes.com/wp-content/up...